Published in J Infect Dis on July 01, 1988
New variants of Vibrio cholerae O1 biotype El Tor with attributes of the classical biotype from hospitalized patients with acute diarrhea in Bangladesh. J Clin Microbiol (2002) 4.54
Analysis of the roles of antilipopolysaccharide and anti-cholera toxin immunoglobulin A (IgA) antibodies in protection against Vibrio cholerae and cholera toxin by use of monoclonal IgA antibodies in vivo. Infect Immun (1993) 1.52
Preliminary assessment of the safety and immunogenicity of live oral cholera vaccine strain CVD 103-HgR in healthy Thai adults. Infect Immun (1989) 1.41
Construction of nontoxic derivatives of cholera toxin and characterization of the immunological response against the A subunit. Infect Immun (1995) 1.20
Rotavirus-associated diarrhea in rural Bangladesh: two-year study of incidence and serotype distribution. J Clin Microbiol (1991) 1.18
Genomic relatedness of the new Matlab variants of Vibrio cholerae O1 to the classical and El Tor biotypes as determined by pulsed-field gel electrophoresis. J Clin Microbiol (2005) 1.13
Production and sequence validation of a complete full length ORF collection for the pathogenic bacterium Vibrio cholerae. Proc Natl Acad Sci U S A (2008) 1.08
Study of epitopes of cholera enterotoxin-related enterotoxins by checkerboard immunoblotting. Infect Immun (1990) 1.06
Heat-stable enterotoxin of enterotoxigenic Escherichia coli as a vaccine target. Infect Immun (2010) 0.98
Review of oral cholera vaccines: efficacy in young children. Infect Drug Resist (2011) 0.97
Spatial and environmental connectivity analysis in a cholera vaccine trial. Soc Sci Med (2009) 0.97
Vibrio cholerae O1 infection induces proinflammatory CD4+ T-cell responses in blood and intestinal mucosa of infected humans. Clin Vaccine Immunol (2011) 0.94
Immunogenicity of two formulations of oral cholera vaccine comprised of killed whole vibrios and the B subunit of cholera toxin. Infect Immun (1989) 0.93
Rapid and scalable plant-based production of a cholera toxin B subunit variant to aid in mass vaccination against cholera outbreaks. PLoS Negl Trop Dis (2013) 0.92
Culture adaptation and characterization of group A rotaviruses causing diarrheal illnesses in Bangladesh from 1985 to 1986. J Clin Microbiol (1991) 0.90
Safety and immunogenicity of single-dose live oral cholera vaccine strain CVD 103-HgR, prepared from new master and working cell banks. Clin Vaccine Immunol (2013) 0.85
Immunogenicity in Peruvian volunteers of a booster dose of oral cholera vaccine consisting of whole cells plus recombinant B subunit. Infect Immun (1995) 0.83
Oral cholera vaccine development and use in Vietnam. PLoS Med (2014) 0.83
Assessing effects of cholera vaccination in the presence of interference. Biometrics (2014) 0.82
The utility of human challenge studies in vaccine development: lessons learned from cholera. Vaccine (Auckl) (2011) 0.82
Killed oral cholera vaccines: history, development and implementation challenges. Ther Adv Vaccines (2014) 0.81
Cost-effectiveness of oral cholera vaccine in a stable refugee population at risk for epidemic cholera and in a population with endemic cholera. Bull World Health Organ (1998) 0.80
Active immunization in the United States: developments over the past decade. Clin Microbiol Rev (2001) 0.80
Incidence of severe diarrhoea due to Vibrio cholerae in the catchment area of six surveillance hospitals in Bangladesh. Epidemiol Infect (2015) 0.80
Critical analysis of compositions and protective efficacies of oral killed cholera vaccines. Clin Vaccine Immunol (2014) 0.79
Effectiveness of the WC/rBS oral cholera vaccine in the prevention of traveler's diarrhea: a prospective cohort study. Hum Vaccin Immunother (2013) 0.79
Vaccines against enteric infections for the developing world. Philos Trans R Soc Lond B Biol Sci (2015) 0.78
Protection of rat intestine against cholera toxin challenge by monoclonal anti-idiotypic antibody immunization via enteral and parenteral routes. Infect Immun (1991) 0.77
Travellers' diarrhoea - pros and cons of different prophylactic measures. Wien Klin Wochenschr (2009) 0.77
Vaccines against human diarrheal pathogens: current status and perspectives. Hum Vaccin Immunother (2014) 0.76
Cholera Outbreaks in Urban Bangladesh In 2011. Epidemiology (Sunnyvale) (2013) 0.75
Comparison of the reactivities and immunogenicities of procholeragenoid and the B subunit of cholera toxin in Thai volunteers. Infect Immun (1989) 0.75
Protection against cholera from killed whole-cell oral cholera vaccines: a systematic review and meta-analysis. Lancet Infect Dis (2017) 0.75
Test for enterotoxigenic Escherichia coli using Y-1 adrenal cells in miniculture. Infect Immun (1975) 13.58
Human reovirus-like agent as the major pathogen associated with "winter" gastroenteritis in hospitalized infants and young children. N Engl J Med (1976) 7.57
Reviews of evidence regarding interventions to reduce tobacco use and exposure to environmental tobacco smoke. Am J Prev Med (2001) 7.47
Travelers' diarrhea in Mexico. A prospective study of physicians and family members attending a congress. N Engl J Med (1976) 6.52
Developing an evidence-based Guide to Community Preventive Services--methods. The Task Force on Community Preventive Services. Am J Prev Med (2000) 6.43
Prostitution and risk of HIV: female prostitutes in London. BMJ (1993) 6.06
The body-mass index of twins who have been reared apart. N Engl J Med (1990) 5.11
Special Escherichia coli serotypes among enterotoxigenic strains from diarrhoea in adults and children. Med Microbiol Immunol (1976) 4.95
Endemic cholera in rural Bangladesh, 1966-1980. Am J Epidemiol (1982) 4.93
Seasonal affective disorder. A description of the syndrome and preliminary findings with light therapy. Arch Gen Psychiatry (1984) 4.72
Reproductive-tract infections in women in low-income, low-prevalence situations: assessment of syndromic management in Matlab, Bangladesh. Lancet (1999) 4.67
Changing disease patterns in patients with AIDS in a referral centre in the United Kingdom: the changing face of AIDS. BMJ (1991) 4.67
Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up. Lancet (1990) 4.62
Does rectal gonorrhoea reflect unsafe sex? Lancet (1991) 3.99
Prostitute women and public health. BMJ (1988) 3.76
Surveillance of patients attending a diarrhoeal disease hospital in Bangladesh. Br Med J (Clin Res Ed) (1982) 3.75
Attachment of Vibrio cholerae serogroup O1 to zooplankton and phytoplankton of Bangladesh waters. Appl Environ Microbiol (1990) 3.73
Priorities among recommended clinical preventive services. Am J Prev Med (2001) 3.70
Enterotoxigenic Escherichia coli isolated from food. J Infect Dis (1977) 3.52
Cholera control. Lancet (1994) 3.38
Enterotoxigenic Escherichia coli and Reovirus-like agent in rural Bangladesh. Lancet (1976) 3.38
Laboratory investigation of diarrhea in travelers to Mexico: evaluation of methods for detecting enterotoxigenic Echerichia coli. J Clin Microbiol (1976) 3.34
Microtiter ganglioside enzyme-linked immunosorbent assay for vibrio and Escherichia coli heat-labile enterotoxins and antitoxin. J Clin Microbiol (1980) 3.30
Diarrhoea associated with heat-stable enterotoxin-producing strains of Escherichia coli. Lancet (1975) 3.27
Detection of Vibrio cholerae O1 in the aquatic environment by fluorescent-monoclonal antibody and culture methods. Appl Environ Microbiol (1990) 3.21
Optic flow is used to control human walking. Nat Neurosci (2001) 3.12
Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine. J Infect Dis (1984) 3.07
High-molecular-weight plasmid correlates with Escherichia coli enteroinvasiveness. Infect Immun (1982) 2.95
A comparison of three verbal autopsy methods to ascertain levels and causes of maternal deaths in Matlab, Bangladesh. Int J Epidemiol (1998) 2.86
Prophylactic doxycycline for travelers' diarrhea. Results of a prospective double-blind study of Peace Corps volunteers in Kenya. N Engl J Med (1978) 2.86
Field trial of oral cholera vaccines in Bangladesh. Lancet (1986) 2.85
Effect on mortality of community-based maternity-care programme in rural Bangladesh. Lancet (1991) 2.82
Epidemic diarrhea at Crater Lake from enterotoxigenic Escherichia coli. A large waterborne outbreak. Ann Intern Med (1977) 2.80
Candida albicans resistance in AIDS. J Infect (1991) 2.78
Seroepidemiological studies of El Tor cholera in Bangladesh: association of serum antibody levels with protection. J Infect Dis (1985) 2.78
Long-term radiation complications following conservative surgery (CS) and radiation therapy (RT) in patients with early stage breast cancer. Int J Radiat Oncol Biol Phys (1992) 2.78
Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. J Clin Oncol (1994) 2.77
Enterotoxigenic Escherichia-coli-associated diarrheal disease in Apache children. N Engl J Med (1975) 2.74
The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer. N Engl J Med (1996) 2.74
Microtiter solid-phase radioimmunoassay for detection of Escherichia coli heat-labile enterotoxin. Infect Immun (1977) 2.72
Reduction of cholera in Bangladeshi villages by simple filtration. Proc Natl Acad Sci U S A (2003) 2.68
Failure of sanitary wells to protect against cholera and other diarrhoeas in Bangladesh. Lancet (1976) 2.64
El Tor cholera with severe disease: a new threat to Asia and beyond. Epidemiol Infect (2009) 2.60
Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial. J Infect Dis (1988) 2.57
Improved thin-layer chromatographic method for the separation of major phospholipids and glycolipids from plant lipid extracts and phosphatidyl glycerol and bis(monoacylglyceryl) phosphate from animal lipid extracts. J Chromatogr (1977) 2.55
HTLV-III: should testing ever be routine? Br Med J (Clin Res Ed) (1986) 2.51
Radiation therapy of early carcinoma of the breast without mastectomy. Cancer (1980) 2.49
Predisposition for cholera of individuals with O blood group. Possible evolutionary significance. Am J Epidemiol (1985) 2.49
Studies of cellular immunity in male homosexuals in London. Lancet (1983) 2.41
An educational intervention for altering water-sanitation behaviors to reduce childhood diarrhea in urban Bangladesh. II. A randomized trial to assess the impact of the intervention on hygienic behaviors and rates of diarrhea. Am J Epidemiol (1987) 2.38
Experimental non-O group 1 Vibrio cholerae gastroenteritis in humans. J Clin Invest (1990) 2.33
Virulence and phenotypic characterization of Yersinia enterocolitica isolated from humans in the United States. J Clin Microbiol (1983) 2.32
Plasmid-mediated resistance to nalidixic acid in Shigella dysenteriae type 1. Lancet (1987) 2.32
The complete set of predicted genes from Saccharomyces cerevisiae in a readily usable form. Genome Res (1997) 2.31
Rape and subsequent seroconversion to HIV. BMJ (1989) 2.26
Twenty-four-hour recall, knowledge-attitude-practice questionnaires, and direct observations of sanitary practices: a comparative study. Bull World Health Organ (1987) 2.24
The relationship between shaved margin and inked margin status in breast excision specimens. Cancer (1997) 2.22
Improved methodology for analyzing local and distant recurrence. J Clin Oncol (1990) 2.21
Methods for systematic reviews of economic evaluations for the Guide to Community Preventive Services. Task Force on Community Preventive Services. Am J Prev Med (2000) 2.20
Tissue-culture assay of antibodies to heat-liable Escherichia coli enterotoxins. N Engl J Med (1974) 2.20
Intestinal antibody responses after immunisation with cholera B subunit. Lancet (1982) 2.13
Classical Vibrio cholerae biotype displaces EL tor in Bangladesh. Lancet (1983) 2.12
Analysis of cosmetic results following primary radiation therapy for stages I and II carcinoma of the breast. Int J Radiat Oncol Biol Phys (1979) 2.10
Methods for priority setting among clinical preventive services. Am J Prev Med (2001) 2.05
Decline in maternal mortality in Matlab, Bangladesh: a cautionary tale. Lancet (1998) 2.04
Three-year prospective study of HTLV-III/LAV infection in homosexual men. Lancet (1986) 2.04
Enterotoxigenic Escherichia coli isolated from patients at a hospital in Dacca. J Infect Dis (1977) 2.03
New virulence-associated plasmid in Yersinia enterocolitica. J Clin Microbiol (1982) 2.03
To boost or not to boost, and how to do it. Int J Radiat Oncol Biol Phys (1991) 2.02
Anaphase structure in mitotic cells typified by spindle elongation. J Ultrastruct Res (1966) 1.98
Vicilin with carboxy-terminal KDEL is retained in the endoplasmic reticulum and accumulates to high levels in the leaves of transgenic plants. Plant J (1992) 1.96
Impact of measles vaccination on childhood mortality in rural Bangladesh. Bull World Health Organ (1990) 1.95
Pathologic predictors of early local recurrence in Stage I and II breast cancer treated by primary radiation therapy. Cancer (1984) 1.95
Accuracy of routinely recorded ethnic group information compared with self-reported ethnicity: evidence from the English Cancer Patient Experience survey. BMJ Open (2013) 1.91
Sexually transmitted diseases in homosexual relationships. J Ir Med Assoc (1972) 1.89
Antimicrobial resistance of Shigella isolates in Bangladesh, 1983-1990: increasing frequency of strains multiply resistant to ampicillin, trimethoprim-sulfamethoxazole, and nalidixic acid. Clin Infect Dis (1992) 1.89
Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. J Clin Oncol (2000) 1.89
Preventing the spread of HIV infection. BMJ (1991) 1.88
Enterotoxigenic Escherichia coli diarrhea of travelers: a prospective study of American Peace Corps volunteers. Johns Hopkins Med J (1977) 1.88
Interruption of shigellosis by hand washing. Trans R Soc Trop Med Hyg (1982) 1.88